Marijuana Sector StockNews

The Cannabis Industry is growing like a “weed.” In 2018 we saw Canada became the first G-7 country to federally legalize private sales of recreational marijuana, Cronos Group (CGC) became the first cannabis producer to list on a major US stock exchange, Tilray (TLRY) became the first cannabis producer to IPO on a major US stock exchange, Michigan voted to legalize recreational marijuana, Oklahoma and Utah legalized medical marijuana, California’s recreational marijuana sales began, and Portugal legalized medical marijuana.

Though cannabis is still federally illegal in the USA, 10 states and the District of Columbia now allow for recreational marijuana use and 30 allow for medical use. And more states are lining up to join the legalization wave.

Now the focus is now on just how big the global cannabis market could be. A new analysis from Arcview Market Research and BDS Analytics estimates that global marijuana sales will rise 38% in 2019 to $16.9 billion and they predict that number could reach $164 billion by the end of 2025.

Marijuana Today = 1990’s Early Internet
With FDA approvals, Canada legalization, and President Trump pushing for legalization, marijuana is in its “early internet days.” Meaning, the marijuana explosion isn’t done. It’s only beginning and stocks could grow 79,256% as we’ve seen before.. And check out the stocks you should be watching.
Click here for the details.

: MJ | ETFMG Alternative Harvest ETF News, Ratings, and Charts

Will Cannabis Stocks Make a Comeback?

Today's featured article covers the MJ and reveals whether marijuana stocks will make a comeback. Continue reading for all these important investing details.

: TLRY | Tilray, Inc. - Class 2  News, Ratings, and Charts

3 Reasons Shorting Stocks Is a Dangerous Move

This featured article highlights the 3 reasons why shorting stocks is a dangerous move. Continue reading for more details.

: CGC | Canopy Growth Corporation  News, Ratings, and Charts

Canopy Growth (CGC) announces it has acquired a plant-based business

KeyLeaf Life Sciences is becoming part of Canopy Growth

: hexo | HEXO Corp. Common Shares News, Ratings, and Charts

Why Hexo (HEXO) and Molson (TAP) may disappoint with their cannabis beverages

Limited experience for users and poor taste could hinder Hexo and Molson Coors joint venture

: hexo | HEXO Corp. Common Shares News, Ratings, and Charts

Shares of marijuana firm Hexo (HEXO) tank following downgrade from Oppenheimer

Hexo receives a downgrade from Oppenheimer on belief of greater margin pressure than expected

: CRON | Cronos Group Inc. - Common Share News, Ratings, and Charts

Why investors shouldn’t be in a hurry to buy Cronos Group (CRON) shares

Cronos Group still has a lot to prove to Wall Street and investors.

: CGC | Canopy Growth Corporation  News, Ratings, and Charts

A major reason for Canopy Growth's (CGC) disappointing Q4 results

Canopy Growth's share base compensation was much higher than analysts expected

Looking For The Next Big Breakout Stocks? Click Here
Do you want to read the Greatest Trading Book ever written?

Page generated in 0.0064 seconds.